BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 26185136)

  • 41. [The first molecular analysis of a Hungarian HNPCC family: a novel MSH2 germline mutation].
    Czakó L; Tiszlavicz L; Takács R; Baradnay G; Lonovics J; Cserni G; Závodná K; Bartosova Z
    Orv Hetil; 2005 May; 146(20):1009-16. PubMed ID: 15945244
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer).
    Hampel H; Frankel WL; Martin E; Arnold M; Khanduja K; Kuebler P; Nakagawa H; Sotamaa K; Prior TW; Westman J; Panescu J; Fix D; Lockman J; Comeras I; de la Chapelle A
    N Engl J Med; 2005 May; 352(18):1851-60. PubMed ID: 15872200
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Genetic analysis of 45 patients with suspected Lynch syndrome using next-generation sequencing].
    Yao ZG; Cheng XK; Lin CH; Li J; Lyu BB; Li JM; Jing HY; Qin YJ; Sun XC
    Zhonghua Zhong Liu Za Zhi; 2021 Aug; 43(8):843-849. PubMed ID: 34407589
    [No Abstract]   [Full Text] [Related]  

  • 44. Identification and characterization of a novel MLH1 genomic rearrangement as the cause of HNPCC in a Tunisian family: evidence for a homologous Alu-mediated recombination.
    Aissi-Ben Moussa S; Moussa A; Lovecchio T; Kourda N; Najjar T; Ben Jilani S; El Gaaied A; Porchet N; Manai M; Buisine MP
    Fam Cancer; 2009; 8(2):119-26. PubMed ID: 18792805
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biallelic MLH1 SNP cDNA expression or constitutional promoter methylation can hide genomic rearrangements causing Lynch syndrome.
    Morak M; Koehler U; Schackert HK; Steinke V; Royer-Pokora B; Schulmann K; Kloor M; Höchter W; Weingart J; Keiling C; Massdorf T; Holinski-Feder E;
    J Med Genet; 2011 Aug; 48(8):513-9. PubMed ID: 21712435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Distinct mutations in MLH1 and MSH2 genes in hereditary non-polyposis colorectal cancer (HNPCC) families from China.
    Wei W; Liu F; Liu L; Li Z; Zhang X; Jiang F; Shi Q; Zhou X; Sheng W; Cai S; Li X; Xu Y; Nan P
    BMB Rep; 2011 May; 44(5):317-22. PubMed ID: 21615986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients.
    Alemayehu A; Sebova K; Fridrichova I
    Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Contribution of large genomic rearrangements in Italian Lynch syndrome patients: characterization of a novel alu-mediated deletion.
    Duraturo F; Cavallo A; Liccardo R; Cudia B; De Rosa M; Diana G; Izzo P
    Biomed Res Int; 2013; 2013():219897. PubMed ID: 23484096
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations.
    Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK
    Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epigenetic mechanisms in the pathogenesis of Lynch syndrome.
    Peltomäki P
    Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants.
    Pagenstecher C; Wehner M; Friedl W; Rahner N; Aretz S; Friedrichs N; Sengteller M; Henn W; Buettner R; Propping P; Mangold E
    Hum Genet; 2006 Mar; 119(1-2):9-22. PubMed ID: 16341550
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mutational spectrum of Lynch syndrome in cyprus.
    Loizidou MA; Neophytou I; Papamichael D; Kountourakis P; Vassiliou V; Marcou Y; Kakouri E; Ioannidis G; Philippou C; Spanou E; Tanteles GA; Anastasiadou V; Hadjisavvas A; Kyriacou K
    PLoS One; 2014; 9(8):e105501. PubMed ID: 25133505
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical utility gene card for: Lynch syndrome (MLH1, MSH2, MSH6, PMS2).
    Rahner N; Steinke V; Schlegelberger B; Olschwang S; Eisinger F; Hutter P
    Eur J Hum Genet; 2010 Sep; 18(9):. PubMed ID: 20104243
    [No Abstract]   [Full Text] [Related]  

  • 54. Novel germline MLH1 and MSH2 mutations in Latvian Lynch syndrome families.
    Bērziņa D; Irmejs A; Kalniete D; Borošenko V; Nakazawa-Miklaševiča M; Rībenieks K; Trofimovičs G; Gardovskis J; Miklaševičs E
    Exp Oncol; 2012; 34(1):49-52. PubMed ID: 22453149
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability.
    Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N
    Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel germline frameshift mutation in the MLH1 gene in a patient with Lynch syndrome.
    Xu J; Song J; Zhu W; Zuo L; Wu J; Zhang L; Wang T; Guo J
    Cancer Genet; 2023 Jun; 274-275():54-58. PubMed ID: 37001204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
    Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
    JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study.
    Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D
    J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Coexisting somatic promoter hypermethylation and pathogenic MLH1 germline mutation in Lynch syndrome.
    Rahner N; Friedrichs N; Steinke V; Aretz S; Friedl W; Buettner R; Mangold E; Propping P; Walldorf C
    J Pathol; 2008 Jan; 214(1):10-6. PubMed ID: 17973250
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
    Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
    BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.